ClpB-IN-1

CAS No. 1453172-23-0

ClpB-IN-1( —— )

Catalog No. M36349 CAS No. 1453172-23-0

ClpB-IN-1 is a potential antimicrobial agent.ClpB-IN-1 is a potent ClpB inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 51 In Stock
10MG 85 In Stock
25MG 163 In Stock
50MG 257 In Stock
100MG 415 In Stock
200MG Get Quote In Stock
500MG 926 In Stock
1G 1237 In Stock

Biological Information

  • Product Name
    ClpB-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    ClpB-IN-1 is a potential antimicrobial agent.ClpB-IN-1 is a potent ClpB inhibitor.
  • Description
    ClpB-IN-1 (compound 7) is a potent ClpB inhibitor. ClpB-IN-1 is a potential antibacterial agents.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1453172-23-0
  • Formula Weight
    302.37
  • Molecular Formula
    C14H10N2O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (16.54 mM; Ultrasonic (<60°C)
  • SMILES
    C=CCN1C(=S)S\C(C1=O)=C1/C(=O)Nc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martin I, et, al. Screening and evaluation of small organic molecules as ClpB inhibitors and potential antimicrobials. J Med Chem. 2013 Sep 26;56(18):7177-89.?
molnova catalog
related products
  • GSK-2140944

    GSK-2140944 (Gepotidacin) is a novel potent, selective bacterial type II topoisomerase inhibitor in development for the treatment of conventional and biothreat pathogens.

  • GSK-229423

    GSK-229423 is a novel bacterial topoisomerase inhibitor that shows potent inhibition of supercoiling by DNA gyrase from S. aureus with IC50 of 14 nM.

  • Iclaprim

    Iclaprim is a novel specific bacterial Dihydrofolate inhibitor.